One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

HIV-vaccine HVTN 705 trial will start this autumn - picture 1

HIV-vaccine HVTN 705 trial will start this autumn

27 July 2017 10:07

At the The 9th International AIDS Society Conference  in Paris was announced that HIV-vaccine HVTN 705 trial will start this autumn. More than 2 500 south african women will participate in the research. Scientists explained that women will be given  HIV vaccine or a placebo and then followed for three years to see if it stops them becoming infected with HIV.

Janssen, the pharmaceutical company of the giant drug and health company Johnson and Johnson is the developer of the vaccine HVTN 705 and the initiators of the study.

Janssen’s Hanneke Schuitemaker told the conference that the vaccine for the new trial had been developed by Janssen during three separate trials, during which different components and combinations were trialled and the best picked.

“I feel we have reached a pivotal moment in HIV vaccine development,” - said Glenda Gray, scientist , she provided an overview at the symposium

Latest News

Sales started (PRODUCT) RED smartphones iPhone 8 and iPhone 8 Plus

Today on the official portal of Apple will begin selling a special line (PRODUCT) RED smartphones iPhone 8 and iPhone 8 Plus. The red color of the product used by the brand means that part of the proceeds from its sale will be channeled to the Global Fund to Fight AIDS, ...

9 April 10:11

Organ donation between HIV-positive people is gradually becoming more common

At the clinic of Duke University in North Caroline, USA, the first liver transplant from an HIV-positive donor was performed to a recipient with the same HIV status. This was the first such operation in southeast USA.

5 April 19:31

Phase I of HIV vaccine trial begins

This month Phase I of a clinical trial begins to test the safety of vaccine that can prevent HIV infection. The trial will take place on four different sites in the United States. During the research, the ability of the vaccine to mount an immune response against HIV will ...

4 April 07:14

Hornet is a leader in HIV prevention messaging amongst social networks for gay and bisexual men

This week, the global social network for gay and bisexual men, Hornet, issued a statement that it was one of the first, six years ago, to introduce the promotion of HIV testing amongst its users - "Know Your Status". Since this time, there have been 50 million interactions ...

3 April 07:01